Integrated genomic and transcriptomic analysis improves disease classification and risk stratification of MDS with ring sideroblasts.
Gabriele TodiscoMaria CreignouElsa BernardAnn-Charlotte BjörklundPedro Luis MouraBianca TesiTeresa Mortera BlancoBirgitta SanderMonika JanssonGunilla WalldinIndira BarbosaSusanne Erika ReinsbachIsabel Juliana HofmanChrister NilssonTetsuichi YoshizatoMarios DimitriouDavid ChangSvanhildur OlafsdottirSigita Venckute LarssonMagnus TobiassonLuca MalcovatiPetter S WollSten Eirik W JacobsenElli PapaemmanuilEva Hellström LindbergPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
These results provide essential input on the molecular basis of SF3B1-unmutated MDSRS+ and propose HSPC quantification as a prognostic marker in myeloid neoplasms with RS.